Uveitic Macular Edema clinical trials

Explore recruiting uveitic macular edema clinical trials.

Also recruiting in Europe

Uveitic Macular Edema trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE MASKED, SHAM-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF RO7200220 ADMINISTERED INTRAVITREALLY IN PATIENTS WITH UVEITIC MACULAR EDEMA

Spain, Germany, Czechia, France, Italy, Portugal +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE MASKED, SHAM-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF RO7200220 ADMINISTERED INTRAVITREALLY IN PATIENTS WITH UVEITIC MACULAR EDEMA

Portugal, Poland, Italy, Netherlands, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Uveitic Macular Edema trials by city

Uveitic Macular Edema in Toronto Uveitic Macular Edema in Vancouver Uveitic Macular Edema in Montreal Uveitic Macular Edema in Calgary Uveitic Macular Edema in Edmonton Uveitic Macular Edema in Ottawa Uveitic Macular Edema in Winnipeg Uveitic Macular Edema in Quebec City Uveitic Macular Edema in Hamilton Uveitic Macular Edema in Kitchener Uveitic Macular Edema in London Uveitic Macular Edema in Halifax Uveitic Macular Edema in New York Uveitic Macular Edema in Los Angeles Uveitic Macular Edema in Chicago Uveitic Macular Edema in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease